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vector length of the baseline shift exceeded the PRV margin 
during treatment was scored. In these cases, it was 
investigated whether or not this would result in overdose for 
the OAR.  
Furthermore, the change in baseline shift was calculated for 
the first and second half of each fraction as well as for the 
fraction as a whole. The average vector length and standard 
deviation of the change in baseline shift were determined per 
patient and for the population as a whole. Data were 
stratified according to the applied protocol.  
 
Results: Figure 1 shows the results of change in baseline shift 
during treatment. Slightly larger changes in baseline shift 
were seen in the 3x18Gy and 5x11Gy protocol. In 11 out of 
460 treatment fractions, the baseline shift exceeded the PRV 
margin at the end of the treatment fraction. In none of the 
patients this exceeding led to overdosage. 
 
 
Conclusion: Intra-fractional baseline shift can vary 
substantially during treatment, especially in patients treated 
with a 3x18Gy or 5x11Gy protocol. However, clinical impact 
of changes in baseline shift during treatment were not found 
in this study. A single assessment of the baseline shift at the 
start of treatment ensures a safe treatment delivery. 
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Purpose or Objective: In our institution, orthogonal kV X-
rays is at present the preferred imaging method for children 
as imaging dose is a concern. In this study, we varied the 
CBCT acquisition parameters and investigated how much we 
can reduce dose, and still be able to perform a secure bone 
match in clinical practice. 
 
Material and Methods: An Alderson phantom equivalent to an 
adult was CT scanned. Due to the absence of a real child size 
phantom only the head and neck was used. On our Varian 
Novalis Tx accelerator, we performed 12 full-fan 200° CBCT 
scans with different parameter settings. The number of 
projections, mA and ms were systematically decreased, while 
kV was constantly at 100. After each scan an automatic bone 
match was performed to investigate the ability to perform 
this kind of match, since this is our procedure in clinical 
practice. The image quality of the scans was visually 
inspected for noise and artefacts. Six of the scans were 
chosen for dose measurements relative to the standard 
preset for these types of scans. The relative dose 
measurements were performed using the RTI Barracuda 
system, consisting of a DCT10-pencil ion chamber positioned 
in the centre of the CTDI 16 cm diameter cylindrical 
phantom. The parameters from the scan comprising the 
largest dose reduction and with the ability to match were 
used for a new CBCT preset. The phantom was CBCT scanned 
with the old and the new preset. Additionally the phantom 
was four times repositioned slightly different and re-scanned. 
Four RTT’s independently matched these CBCT scans with the 
original CT scan offline in order to validate the new preset. 
 
Results: A dose reduction of up to a factor of 14 could be 
achieved by changing the full-fan CBCT scan parameters from 
20 mA and 20 ms (standard preset) to 10 mA and 2 ms. 
Reducing the number of projections from 650 to 360 added 
no further dose reduction. The new imaging preset results in 
a total dose of only 0.39 mGy compared to 0.14 mGy for 2 
orthogonal X-ray imaging. Table 1 shows the average match 
difference between the different presets. The maximum 
deviations are +/-0,5 mm and 0.6º. Figure 1a+b show the 





Conclusion: It is possible for RTT’s to use low dose daily 
CBCT scans in paediatric radiation therapy and still perform a 
reliable automatic bone match. 
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Purpose or Objective: This work develops risk assessments of 
solid secondary malignancies (SMN) after radiotherapy (RT) in 
survivors of childhood and adolescent Hodgkin Lymphoma 
(HL) patients (pts) using the Schneider’s dose-response model 
for solid cancers induction (Theoretical Biology and Medical 
Modelling 2011), comparing conventional technique (3D-CRT) 
with IMRT delivered with Helical Tomotherapy (HT). 
 
